All posts by imreal

Redi.Health Sees Tremendous Growth for Platform that Empowers Patients to Understand, Manage and Track their Health with Digital Support


News Image

Technology is revolutionizing healthcare, which is an industry that is long overdue for innovation. Redi.Health is helping simplify an extremely complex industry so patients can take more control of their healthcare journey.

Today, Redi.Health, provider of the leading health management technology that puts patient support in your pocket, is announcing it has secured growth capital led by Refinery Ventures, with participation from repeat investors MCP, Rev1 Ventures, and M25. The funding follows the company’s recent seed financing round and helps support increased demand for the platform, which has seen continued adoption from patients across the nation.

“Redi.Health aligns with our mission in developing companies that change the way we see the world,” said Tim Schigel, managing partner at Refinery Ventures. “Technology is revolutionizing healthcare, which is an industry that is long overdue for innovation. Redi.Health is helping simplify an extremely complex industry so patients can take more control of their healthcare journey. We understand how vital it is for outcomes and look forward to working with the Redi.Health team through its next phase of growth.”

Redi.Health combines health management technology and pharmaceutical manufacturer support into one platform to enable patients to manage their complete health with a single interface. The company has integrated a more robust data algorithm that allows Redi.Health to simultaneously connect patients to support offered by healthcare stakeholders while providing insights to those stakeholders to ensure the right support is getting to the right patient at the right time.

“For patients managing chronic conditions, access to information and support about medications, symptoms, wellness tips and more is critical,” said Luke Buchanan, co-founder, and CEO of Redi.Health. “We are dedicated to delivering a truly patient-centric model that improves quality of life, and we know we’re filling an obvious need for the market and patient community. Our growth confirms it.”

Redi.Health recently forged partnerships with several healthcare heavyweights like GoodRx and ScriptDrop, as well as a collaboration with Labcorp that integrates the Labcorp Drug Development Patient Access Solutions with Redi.Health’s digital support platform to more seamlessly connect patients and providers.

The company expects to continue to accelerate in 2023 with more advancements for improved patient outcomes. For more information about Redi.Health’s groundbreaking approach, visit https://www.redi.health/.

About Redi.Health

Redi.Health empowers patients with chronic conditions to understand, manage and track their total health through digital support. Combining health management technology and pharmaceutical manufacturer support into one tool, Redi.Health provides a mobile platform that allows patients to manage everything from multiple medications and symptoms to diet and exercise. By delivering a pathway for pharmaceutical companies, providers, and patients to connect and engage, Redi.Health customizes the complete health journey to drive better health outcomes.

Share article on social media or email:

Pandemic Preparedness & Rapid Response — Managing Clinical Research During a Public Health Emergency, Upcoming Webinar Hosted by Xtalks


Learn what hurdles must be overcome while conducting effective clinical research in a pandemic scenario, and the advantages of having an established pandemic preparedness and rapid response model in place.

The unprecedented disruptions caused by the COVID-19 pandemic were felt across the drug development industry, triggering renewed interest from government, biotech and biopharma entities alike to invest in pandemic preparedness initiatives.

PPD, part of Thermo Fisher Scientific, immediately recognized an industry-wide, unmet need to safeguard against future disruptions to the clinical development process and spearheaded the generation of a pandemic preparedness and rapid response delivery model. This program represents an executable action plan to deliver high-quality clinical data in the face of rapidly changing regulatory landscapes, compressed timelines and resourcing challenges.

The featured speakers will discuss how they integrated lessons learned from the COVID-19 pandemic into an executable action plan to: Streamline feasibility and start-up processes; Build safeguards into bioprocess and manufacturing; Leverage digital tools to enhance regulatory intelligence and the patient journey; And more.

Register for this webinar to learn what hurdles must be overcome while conducting effective clinical research in a pandemic scenario, and the advantages of having an established pandemic preparedness and rapid response model in place.

Join experts from Thermo Fisher Scientific, Vanessa Elharrar, MD, MPH, Vice President, Vaccines Business Strategy Lead, PPD; Kelly Howard, Vice President, Commercial Operations Global Viral Vector Services and Advanced Therapies (mRNA, pDNA, Cell Therapy), Pharma Services Group, Thermo Fisher Scientific; Jennifer Crager, Executive Director, Digital and Decentralized Solutions, PPD; Dr. Ilse-Maria Nolan, Senior Director Regulatory Affairs, PPD; and Jenna McDonnell (BSc), Senior Director, Consulting, Innovation & Strategy, PPD, for the live webinar on Monday, October 31, 2022, at 11am EDT (3pm GMT/UK).

For more information, or to register for this event, visit Pandemic Preparedness & Rapid Response — Managing Clinical Research During a Public Health Emergency.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Benefits of Bayesian Dose Escalation Designs for Oncology Studies, Upcoming Webinar Hosted by Xtalks


These flexible methods may be more appropriate than those initially designed for chemotherapy drug development.

As acceptance of flexible trial designs continues to advance, many sponsors are increasingly exploring alternate methods of dose escalation to support identification of a maximum tolerated dose (MTD) and recommended Phase II dose (RP2D) in open-label early phase or First-in-Human studies. Bayesian dose escalation designs have also coincided with advances in oncology therapy development, such as immunotherapies and antibody drug conjugates. These flexible methods may be more appropriate than those initially designed for chemotherapy drug development.

In this webinar, the featured speaker will discuss and cover: Common types of open-label adaptive dose escalation designs; Comparisons with rule-based designs; How to apply and use these designs in oncology therapy development; And how to determine which design is best suited for a clinical trial.

Register to learn the benefits of Bayesian dose escalation designs for oncology therapy development.

Join Vanessa Beddo, PhD, VP, Biostatistical Consulting, Allucent, for the live webinar on Monday, October 31, 2022, at 11am EDT (3pm GMT/UK).

For more information, or to register for this event, visit Benefits of Bayesian Dose Escalation Designs for Oncology Studies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Computer Vision Leader VISUA Launches Low-Code & No-Code Implementation


Our No-Code and Low-Code implementations now put the power of VISUA’s Computer Vision stack in everyone’s hands, no matter their size or development capabilities.

Leading Computer Vision (Visual-AI) company, VISUA has launched two new ways to integrate Computer Vision into any workflow without the need for developers.

VISUA enjoys a broad customer base comprising leading global companies like Brandwatch, TVEyes and GearLaunch, covering sectors as diverse as brand monitoring, brand protection, cyber security and print-on-demand marketplaces. All these companies make use of VISUA’s API to send media for processing and to control the numerous options available during processing. Finally, the API delivers the results back to them in JSON or XML format. The data can then be integrated into their own data sources to deliver a combined dashboard of data to their clients.

However, in recent years, new sectors have begun to take an interest in how Computer Vision can help them meet their business challenges, often driven by regulatory requirements that demand controls and oversight on the sale of counterfeit and trademark/copyright infringing products, or simply to moderate harmful content, such as hate speech on their platform. Many of these are not ‘high-tech’ companies and have relatively small developer teams focused on development of their core business requirements. As such, they either have no ability to work with an advanced API or simply have no need to integrate the results of processed media into their platform.

Having identified API-less access to its suite of Computer Vision technologies as a key opportunity, VISUA has worked to deliver workable solutions and now announces the launch of two new ways to leverage the power of Computer Vision:

No-Code Computer Vision

Clients can place media to be processed in an authenticated repository. VISUA’s engine will collect the files and process them. Extracted data is then placed in a VISUA dashboard for the client to interrogate.

Where the client needs to link the findings of a specific image or video back to their platform, they simply add the listing, order or post details into the file’s metadata, which is then converted into a link that points to the relevant page on the client’s site.

This implementation is ideal for clients with lower processing volume requirements and/or have no developer resource to work with the API.

Low-Code Computer Vision

Clients use the API to send media to our engine and provide corresponding listing/order/post details. Once processed, the extracted data is presented to the client via the VISUA dashboard.

This is ideal for clients with higher volume processing needs and/or some resource to use the API, but have no need to integrate the extracted data into their platform.

VISUA, co-founder and CTO, Alessandro Prest explains: “APIs are the key to accessing the best external systems and technologies across the world, but their use is not for everyone. Our No-Code and Low-Code implementations now put the power of VISUA’s Computer Vision stack in everyone’s hands, no matter their size or development capabilities.”

Luca Boschin, VISUA, co-founder and CEO, adds: “We have seen a growing demand for computer vision by marketplaces and content platforms. Perhaps because perceptions and attitudes towards platforms that allow the sale of fake & copyright/trademark infringing goods, and harmful content continues to grow ever more negative. Or that new legislation, like the Digital Services Act in Europe, are forcing platforms and providers of intermediary services to deal with these issues. When it comes to detecting and blocking visual content, the only way to do it effectively is using computer vision. But many of these companies have limited development capabilities, so our No-Code and Low-Code options have been developed to allow any company with a need to harness Computer Vision with a means to do so.”

–ENDS–

Website | Twitter |LinkedIn | YouTube

About VISUA

VISUA boasts best-in-class Visual-AI that powers the world’s leading brand and sponsorship monitoring, brand protection, and authentication platforms. VISUA delivers technologies such as logo/mark detection, text detection, object & scene detection and visual search, that are used by world leading companies for applications as varied as sports sponsorship monitoring, social listening, and phishing detection, to holographic authentication and counterfeit product detection. Its Visual-AI technology is proven to deliver the highest precision with instant learning, at unlimited scale, and is adaptable for any use case. VISUA believes in People-First AI, they see a world where Visual-AI will lift humanity out of the mundane, empowering a society that focuses more on creativity and collaboration and less on binary tasks, and empowering services and solutions that humans alone simply can’t deliver.

For media inquiries please contact:

Franco De Bonis

Marketing Director

VISUA

press@visua.com

Share article on social media or email:



Laila’s Gift Announces Year-End Fundraising Gala and GoFundMe Campaign to Benefit Children With Special Needs


“As a special needs mom, this movement is near and dear to my heart. Laila’s Gift aims to bring a smile to children with special needs and their families because tomorrow is never promised and their collective perseverance to overcome hardships deserves to be celebrated!” said Shari Bailey.

Laila’s Gift, a nonprofit shedding light on the challenges of special needs families, announces its year-end fundraising gala and GoFundMe campaign titled “Help Celebrate the Lives of Special Needs Children” to benefit the organization. Laila’s Gift is a champion for the special needs community by providing ongoing resources, support and encouragement.

The Gifter’s Gala, is to be held on Dec. 17 2022 at The Port Discovery Children’s Museum Downtown Baltimore, MD, will include fundraising efforts and be a night filled with special needs awareness, insights from keynote speakers, and community and professional recognitions. The charitable initiative is the brainchild of change influencer Shari Bailey, the mother of 8-year-old twin daughters, one of whom has the rare congenital disorder, Jacobsen Syndrome.

The goal is to raise $100,000 by Dec. 31 from the event and crowdsourcing campaign to celebrate the birthdays of children with special needs throughout 2023, acknowledging the many challenges they face. The nonprofit will throw a birthday bash for each child, give them a personalized gift and feature the story of the celebration on its digital platforms.

“As a special needs mom, this movement is near and dear to my heart,” said Bailey. “Laila’s Gift aims to bring a smile to children with special needs and their families because tomorrow is never promised and their collective perseverance to overcome hardships deserves to be celebrated! My girls inspire me to help others and share my skills and knowledge with a community whose lives have been impacted by raising a child with special needs. To me, their child’s unique gift is a blessing they share with every person they encounter. The more we understand their conditions and work together to help them feel included is of utmost importance to the work of our nonprofit.”

For many children with special needs, each birthday is a milestone due to health complications and other adversities. Bailey’s daughter, Laila, was diagnosed with Jacobsen Syndrome at birth. The rare congenital condition occurs in approximately 1 in 100,000 newborns. Roughly 20% to 25% of all infants with this disorder pass away before age two.

Additional fundraising endeavors include the recent launch of zigglebee, a children’s book by Laila’s sister, Lana, encouraging engagement through creativity and the arts. A percentage of proceeds from each book will go towards research for Jacobsen Syndrome.

For more information and ways to give, click here.

About Laila’s Gift and Shari Bailey:

Laila’s Gift is a nonprofit organization established in 2022 to shed light on the challenges of being a special needs parent and family member. It also promotes inclusion by highlighting the blessing each special needs child brings to the people they encounter. Founder Shari Bailey is mom to twin daughters, one of whom was diagnosed with Jacobsen Syndrome at birth. She tirelessly works to raise awareness about the rare congenital condition and is a spokesperson for raising children with special needs through her “Making a Difference” campaign.

For more information, visit her website at http://www.iamsharibee.com.

Share article on social media or email:

Ziosoft Highlights Virtual Surgical Visualization Solutions at Annual American College of Surgeons Conference


These analytical tools assist surgeons to see and think in 3D, crossing the bridge between the gap of diagnostic readers to the operating table. It also can help decrease operative times while improving surgical outcomes.

Ziosoft, a pioneer in 3D/4D AI medical visualization, will highlight its virtual surgical visualization solutions at the annual American College of Surgeons (ACS) conference being held October 16-20, 2022 in San Diego, California. The company will showcase software tools, such as lung and liver segmentation, to help enable efficient surgical planning analysis.

“Ziosoft’s segmentation analysis software provides extensive capabilities for surgical planning,” said Rajeev Taitriya, vice president of marketing and business development for Ziosoft. “These analytical tools assist surgeons to see and think in 3D, crossing the bridge between the gap of diagnostic readers to the operating table. It also can help decrease operative times while improving surgical outcomes.”

Several features of the Ziostation2 system software assist to enable these advantages. These include allowing for an anatomical map prior to the operating procedure, which can lead to reduced time under anesthesia, and determining if the patient is a good candidate for a particular surgical approach. It also helps eliminate “investigative surgery,” as well as allowing for Rapid Prototypes to be printed for actual 3D planning, going beyond the screen of virtual 2D visualization.

For example, Ziosoft’s CT lung resection planning offers high precision automatic segmentation of the lungs, lung lobes, bronchi, pulmonary arteries and veins, enabling lung resection proposals based on bronchial or arterial anatomy. For CT liver analysis, the protocol is used to segment image masks of the hepatic artery, portal vein and hepatic vein using data of the liver scanned with a contrast material and measure the volumes including liver segments and lesions.

“Our software is designed to help streamline planning and provide outstanding image quality,” said Taitriya. “The goal is to enhance workflow and reduce unnecessary procedures, while enabling better patient outcomes. We believe it can be invaluable in the surgical environment for optimizing excellence in patient care.”

The Ziosoft platform also offers its unique PhyZiodynamics 3D/4D solution, as well as the recently introduced Zioflex, a monthly subscription program designed to provide a risk free introduction of Ziosoft’s many AV clinical applications. The software is vendor neutral and can be compatible with the clinician’s existing hardware, hence mitigating the need for expensive capital outlays.

About Ziosoft.

Ziosoft provides a comprehensive multi-modality, 3D/4D advanced processing and viewing solution for a wide variety of specialties. Its customizable platform provides automated workflow to maximize efficiency. It is also a scalable, enterprise platform for “anywhere” accessibility and, as a software-only solution, it is simplified to minimize cost of ownership. Ziosoft is part of the Los Angeles-based Nantworks a consortium of companies led by Patrick Soon-Shiong, MD, the past founder of Abraxis BioScience, current CEO of Nantworks, founder, executive chairman and chief science officer for ImmunityBio. He is also the owner of the Los Angeles Times and San Diego Tribune. For further information on Ziosoft, visit http://www.ziosoftinc.com.

# # #

Share article on social media or email:

Families in India Face Ongoing Challenges When Coping With Rare Diseases


News Image

Every year, countless families in India struggle to provide care to family members with rare diseases. Until we achieve greater global collaboration and an increased focus on developing orphan drugs, these families will be left facing a harsh reality

In India, an estimated 70 million people are living with a rare disease.(1) According to a recent report from RARE-X, there are about 10,867 known rare diseases in the world. Most of these maladies are debilitating, life-long, and often require costly treatments. For families supporting a loved one with a rare disease, the outcome is often bleak. Many families struggle with social stigma and limited access to specialized healthcare. Most pharmaceutical advances and treatments for rare diseases are developed in the western world, making them out of reach, even when they are available in the country, due to their abnormally high cost.

“Every year, countless families in India struggle to provide care to family members with rare diseases. Until we achieve greater global collaboration and an increased focus on developing orphan drugs, these families will be left facing a harsh reality,” according to Dr. Harsha Rajasimha, Founder and Chairman of the Indo-US Organization for Rare Diseases (IndoUSrare), a not-for-profit organization that seeks to bridge the gap that exists in the world when it comes to rare diseases, specifically in children.

Dr. Rajasimha lost a child to a rare disease in 2012 and has been a global rare disease advocate for more than ten years. In response to growing concerns in India, Dr. Rajasimha formed IndoUSrare in 2019. IndoUSrare aims to foster and support global collaboration to accelerate progress toward successful prevention, diagnosis, treatment, and management of rare diseases.

For families in India, there is a great sense of urgency when it comes to the treatment of rare diseases. Early diagnosis and intervention have the power to save lives and allow those with rare diseases the chance to enjoy a better quality of life. However, patients’ and families’ awareness of experts and resources available within the country and in the US/EU is extremely limited.

Dr. Inusha Panigrahi from the Department of Advanced Pediatrics Centre, PGI — who deals with rare diseases — stated recently, “There is a portal of the Government of India where private entities donate funds for the treatment. The awareness is so low that only Rs 65,000 were donated in the past month. A single injection for rare diseases like spinal muscular atrophy (SMA) costs Rs 16 crore. Now, who will bear the cost of treatment for such patients? The Central Government also has limited resources.”(2)

In May of this year, India’s Union Ministry of Health & Family Welfare Rare Diseases Cell in New Delhi raised the rare disease treatment grant from Rs 20 lakh to Rs 50 lakh. This one-time grant for the lifelong treatment of a patient’s rare disease provides financial support to patients with all three groups of rare diseases as defined in the National Policy for Rare Diseases (NPRD). Select Centers of Excellence (CoEs) were notified and authorized in the NPRD 2021 to receive this money and prioritize patients for treatment.(3) However, most patients, pharma companies, and primary care doctors are unaware of these resources. Omnichannel communications are critical for raising awareness and building trust among various stakeholders. This requires resources and funding.

Due to these constraints, India continues to fall behind in health research data, patient registries, natural history studies, and clinical research for rare diseases. It is estimated that compared to developed countries, India is lagging by nearly 40 years in recognizing the importance of combatting rare diseases.(4)

Further adding to the complexity of the situation for families in India, some rare diseases are not officially acknowledged by the NPRD, such as Motor Neuron Diseases (MNDs) like ALS or Lou Gehrig’s Disease. This makes it harder for patients in India with these types of diseases to access government support even when available.

To answer the cries of the millions affected in India, through IndoUSrare, Dr. Rajasimha and his team are actively building the necessary bridge between patients and government entities that can affect change. IndoUSrare has been building a multinational alliance of over 50 synergistic organizations and recently added Dr. Shyama Narang Foundation (MND Trust), a registered, not-for-profit organization located in Bengaluru, India, to their growing network of collaborators.

“We are extremely happy to collaborate with IndoUSrare as there is synergy in our mutual goals and objectives. Headquartered at the BRAINS Hospital, our common purpose will lead us to find a cure for many of these rare diseases through persistent collaborations with research institutions and clinicians worldwide,” said Vasanth Rao, Founder Trustee of the MND Trust. IndoUSrare and MND Trust will advocate for the addition of unacknowledged rare diseases, such as MND/ALS, to NPRD and the ICMR (Indian Council of Medical Research) National Registry for Rare Diseases. IndoUSrare has connected at least two Indian patients with MND/ALS with existing organizations with expertise and resources for these specific diseases. There is an urgent need for scalable technology platforms that can help establish new disease-specific or broader high-quality patient registries and natural history studies for rare diseases in India.

IndoUSrare is utilizing a technology platform to scale their patient support and care navigation services. This platform will enable a growing number of patients to contact IndoUSrare for the latest information, expert connections, and tools to help them best manage their specific medical conditions and quality of life. The platform can also connect them to clinical trials where plausible. “We are interested in collaborating with IndoUSrare to take part in any clinical trials or translational research related to rare and complex neurological disorders to ensure patients in India have the same opportunities and access at par with the western world,” says Dr. N K Venkatarama, Founder Chairman of BRAINS, a super-specialty Hospital focused on rare neurological diseases.

Additionally, as part of its greater mission to improve inclusion and diversity in clinical trials, IndoUSrare is helping to match Indian patients living with rare diseases to clinical trials going on in the U.S. and globally. To learn more about the work IndoUSrare is doing to combat the challenges facing families with rare diseases in India and those in diaspora from India in the US or globally, visit https://indousrare.org. Patients and families can submit a “Patient Contact Form” on the website to receive free informational and care navigation services from the organization.

The IndoUSrare team will be presenting a poster at the NORD Summit in Washington DC on October 17th & 18th.

About IndoUSrare

IndoUSrare is a humanitarian non-profit 501(c)(3) tax-exempt public charity organization based in the U.S. Founder and Chairman, Dr. Harsha Rajasimha, who lost a child to a rare disease in 2012, has been a rare disease advocate for more than ten years. To address the unmet needs of diverse patients with rare diseases globally, the leadership team comprised of experienced professionals from research, advocacy, regulatory, and drug development seeks to build cross-border collaborations connecting stakeholders of rare diseases in low- and middle-income regions such as India, with their counterparts and clinical researchers in the U.S. to improve the diversity of clinical trial participants, accelerate research and development, and improve equitable access to life-saving therapies to diverse populations of rare disease patients. Visit https://indousrare.org.

References:

1. Deeksha, Johanna. “India’s abandonment of families living with a child’s rare disease.” January 2022. https://scroll.in/article/1015343/indias-abandonment-of-families-living-with-a-childs-rare-disease.

2. Mishra, Naina. “Fund crunch in PGI, Chandigarh, hinders treatment of rare diseases.” April 2. https://www.tribuneindia.com/news/chandigarh/fund-crunch-in-pgi-chandigarh-hinders-treatment-of-rare-diseases-383085.

3. “Need for urgency in treatment for rare diseases.” Times of India Blog. (2022, August 9). Retrieved October 3, 2022, from https://timesofindia.indiatimes.com/blogs/voices/need-for-urgency-in-treatment-for-rare-diseases/

4. Mona and Shubhangi Patel. “Rare Diseases in India: ‘Orphan’ No More?” July 2022, Observer Research Foundation. https://www.orfonline.org/research/rare-diseases-in-india-orphan-no-more/

Global Wellness Institute Announces Historic Partnership with Fountain Life for the Wellness Moonshot


News Image

We knew we had found perfect partners with whom to take this project to the next level.

The Global Wellness Institute (GWI), the leading research and educational resource for the $4.4 trillion global wellness industry, today announced that Fountain Life will be the exclusive sponsor for The Wellness Moonshot: A World Free of Preventable Disease in 2023. This is a groundbreaking public-private partnership between two organizations whose missions are closely aligned.

The Wellness Moonshot, launched by the GWI in 2017 with the support of medical leaders Dr. Andrew Weil of the University of Arizona, Dr. Michael Roizen of the Cleveland Clinic, and Dr. Richard Carmona, former US Surgeon General, has worked to bring together global wellness leaders to eradicate preventable disease. This initiative has brought its themed monthly wellness education campaigns into global workplaces, schools and homes, impacting over 160 million people. Fountain Life is a fast-growing company that aims to create a newly preventative healthcare model through data-driven technologies that can identify and treat illnesses at their earliest stages.

Fountain Life’s cofounders are high-profile medical leaders and entrepreneurs that know how to make an impact and reach millions: Peter Diamandis, MD, founder of over 20 companies and named one of the World’s 50 Greatest Leaders by Fortune; Bill Kapp, MD, orthopedic surgeon and serial entrepreneur; Robert Harari, MD, surgeon, biomedicine entrepreneur, and stem cell pioneer; and Tony Robbins, philanthropist, entrepreneur, and a household name for his ability to inspire people.

The GWI and Fountain Life’s executive team will work closely together in 2023 to dramatically expand the reach and resources of the Wellness Moonshot to help many millions more people make healthy changes.

The human and economic costs of not focusing on prevention: Creative initiatives that could help move the needle on prevention are direly needed. Global healthcare expenditures have more than doubled in the last two decades, reaching $8.5 trillion annually, but according to the World Health Organization, obesity, diabetes and hypertension rates have also more than doubled in roughly the same time. Seventy-four percent of all deaths globally are now a result of noncommunicable diseases, the vast majority of which are preventable chronic diseases that, the World Economic Forum estimates, will cost the world a staggering $47 trillion by 2030.

The partnership is not only with GWI, but with its sister organization, the Global Wellness Summit. Fountain Life is a Diamond Sponsor of the conference being held in Tel Aviv, Israel from October 31 to November 3 and Dr. Bill Kapp, the company’s CEO, and Rakesh M. Suri, MD, D.Phil, its president and chief medical officer, will be featured on panels on the future of longevity science.

“Fountain Life’s partnership with the Global Wellness Institute and the Wellness Moonshot marks the beginning of a first of its kind campaign to leverage today’s innovators from the medical, health and wellness industries to develop a healthcare model centered around eradicating preventable disease in 2023. By utilizing a data-driven approach that focuses on the diagnosis and prevention of illnesses, Fountain Life may contribute to changing the course of global health by empowering individuals to be the leaders of their own longevity. The Global Wellness Institute brings together international leaders at the forefront of health and wellness, and we are honored to participate in this effort to invent a new health paradigm,” said Bill Kapp, M.D., Fountain Life CEO.

“There are moments in life when the planets align, and that is what happened on a call with Fountain Life leadership. As they described their mission, it was as if they were reading the mission of the Wellness Moonshot,” said Nancy Davis, GWI chief creative officer and executive director. “We knew we had found perfect partners with whom to take this project to the next level. With the prominence of Fountain Life’s executive team, their revolutionary business model, the global reach of the Wellness Moonshot, and our shared commitment to eradicating preventable disease, we could not be more excited about 2023.”

More about Fountain Life: The company brings together some of the world’s leading physicians and scientists to create a new kind of healthcare that is predictive, preventive, personalized and data-driven, using new technologies such as AI and advanced diagnostic testing to catch and treat illnesses (such as cancer, cardiac, metabolic, and neurodegenerative disease) at the earliest stages before they cause harm–giving members the tools to live longer, happier lives. Fountain Life centers are expanding fast globally: open in Naples, Florida; White Plains, New York; Dallas, Texas; and New Delhi, India, and coming soon to Lake Nona, Florida; California; Dubai, UAE; and Toronto, Canada. The expansion also includes partnerships with real estate developers, hospitality management companies, and other wellness-oriented businesses. Through Fountain Health Insurance, the company is the first to provide full coverage of these technologies and put cutting-edge diagnostic tools directly into the hands of families who would not normally be able to afford or have access to them. This employer-sponsored insurance also rewards healthy behavior, while continuing to cover traditional sick-care.

Company founders:


  • Peter Diamandis, MD, is a serial entrepreneur who has started over 20 companies in the areas of longevity, space, venture capital and education. He is the cofounder and vice chairman of Celularity Inc., a cellular therapeutics company.
  • Robert Hariri, MD, PHD, is an accomplished surgeon, biomedical scientist and serial biomedicine and aerospace entrepreneur, who pioneered the use of stem cells to treat a range of life-threatening human diseases. He was the 2018 recipient of the Pontifical Medal for Innovation (awarded by Pope Francis) and received the Thomas Alva Edison Award for technological innovation twice.
  • Bill Kapp, MD, is a board-certified orthopedic surgeon and an expert in diagnosing and treating ailments affecting muscles, bones and joints, as well as sports injuries. He is also a serial entrepreneur who has built multiple businesses and nine Landmark Hospitals.
  • Tony Robbins is the leading life and business strategist in the US and a New York Times best-selling author with over 15 million copies and over 50 million audio business volumes sold globally. He has worked with Bill Clinton, Oprah, Nelson Mandela, Leonardo DiCaprio and many more.

Registration for the 2022 Summit in Tel Aviv is open.

About the Global Wellness Institute: The Global Wellness Institute (GWI), a nonprofit 501(c)(3), is considered the leading global research and educational resource for the global wellness industry and is known for introducing major industry initiatives and regional events that bring together leaders to chart the future. GWI positively impacts global health and wellness by educating public institutions, businesses and individuals on how they can work to prevent disease, reduce stress and enhance the overall quality of life. Its mission is to empower wellness worldwide.

About Fountain Life: Fountain Life brings together the world’s most renowned scientists and physicians to boost longevity and performance, putting health back in healthcare. Fountain Life does this by using cutting-edge Artificial Intelligence (AI) to collect data and gain insights into the human body that have never been possible before. Fountain Life’s data-driven approach enables finding illnesses including cancer, cardiac, metabolic, and neurodegenerative disease early, before they can cause harm. As a result, Fountain Life members operate at peak performance throughout their life, with the aim that they will feel as healthy and vibrant at 100 as they were at 60. Learn more at http://www.fountainlife.com and follow us on LinkedIn, Facebook and Instagram.



American Association of Oral and Maxillofacial Surgeons recognizes award winners during Annual Meeting


News Image

The American Association of Oral and Maxillofacial Surgeons (AAOMS) honored nearly 40 award recipients for their accomplishments in education, research, advocacy and humanitarianism at the association’s 104th Annual Meeting, Scientific Sessions and Exhibition.

The awards presentation was held during the Opening Ceremony of the event – the largest gathering of oral and maxillofacial surgeons in the country – in September.

AAOMS dedicated its Annual Meeting posthumously to J. Thomas Soliday, DDS, of Gettysburg, Penn., speaker of the Association’s House of Delegates from 1995 to 2002. His honors included the 2013 Distinguished Alumnus of the Year Award from the University of Maryland School of Dentistry and the 1999 AAOMS Humanitarian Award for Fellows and Members, along with various state and national leadership awards. Soliday served nearly 20 years as parliamentarian for the Maryland State Dental Association and 10 years as speaker of the American Dental Association House of Delegates (2002-2012).

Mark E. Wong, DDS, FACS, of Houston, Texas, received the Robert V. Walker Distinguished Service Award recognizing significant contributions to the oral and maxillofacial surgery (OMS) specialty. He is professor, chair and program director of the Katz Department of Oral and Maxillofacial Surgery at the University of Texas School of Dentistry at Houston. His career includes serving as president of the American Board of Oral and Maxillofacial Surgery, the American Academy of Craniomaxillofacial Surgeons and the International Board for the Certification of Specialists in Oral and Maxillofacial Surgery.

Other AAOMS award winners are:

  • Clinical Research Award – Peter D. Waite, DDS, MD, FACS, of Irondale, Ala.
  • Committee Person of the Year Award – Deepak G. Krishnan, DDS, FACS, of Cincinnati, Ohio.
  • Daniel M. Laskin Award for an Outstanding Predoctoral Educator – John R. Evans, DDS, of Duvall, Wash.
  • Donald B. Osbon Award for an Outstanding Educator – Eric R. Carlson, DMD, MD, EdM, FACS, of Knoxville, Tenn.
  • Faculty Educator Development Awards – Brian P. Ford, DMD, MD, FACS, of Blue Bell, Pa.; Brian E. Kinard, DMD, MD, of Vestavia, Ala.; and Chi Tonglien Viet, DDS, MD, PhD, of Rancho Cucamonga, Calif.
  • Honorary Fellowship – Carmen Hupp, of Nashville, Tenn.; and John J. Schaefer III, MD, of Mount Pleasant, S.C.
  • Humanitarian Awards for Fellows and Members – Robert H. Lewis Jr., DDS, of Rogers, Ark., and David E. Frost, DDS, MS, of Chapel Hill, N.C.
  • John F. Freihaut Political Activist Award – Jeffrey H. Wallen, DDS, of Myrtle Beach, S.C.
  • Outstanding Legislator of the Year Award – U.S. Reps. Josh Gottheimer (D-N.J.) and Tom Rice (R-S.C.)
  • Presidential Achievement Award – Ronald L. Tankersley, DDS, of Newport News, Va., and Steven R. Nelson, DDS, MS, of Greenwood Village, Colo.
  • Resident Scientific Awards – Caitlyn M. McGue, DDS, of Loma Linda, Calif.; Timothy W. Neal, DDS, of Dallas, Texas; and Sruthi Satishchandran, DMD, of Atlanta, Ga.
  • Special Honorary Fellowship – Cyrus J. Kerawala, BDS, FDSRCS, MBBS, FRCS, president of the British Association of Oral and Maxillofacial Surgeons; Alejandro Martinez, DDS, president of the International Association of Oral and Maxillofacial Surgeons; and Gunaseelan Rajan, BDS, MBBS, PhD, DSc, FDSRCS, president of the Asian Association of Oral and Maxillofacial Surgeons.


— William J. Gies Foundation Award – Jasjit K. Dillon, MBBS, DDS, FDSRCS, FACS, of Bellevue, Wash.

OMS Foundation awards also were announced. In alliance with AAOMS, the Foundation strives to enhance patient care quality and safety through advancing innovation in OMS research and education:

  • OMS Foundation Torch Award – William C. Passolt, CPA, of Mundelein, Ill.
  • OMS Foundation Research Recognition Award – Thomas B. Dodson, DMD, MPH, FACS, of Seattle, Wash.
  • OMS Foundation Gerald E. Hanson Outstanding Service Award – Thomas Williams, DDS, MD, FACS, of Dubuque, Iowa.
  • OMS Foundation Daniel M. Laskin Award – “Safety of Outpatient – Procedural Sedation Administered by Oral and Maxillofacial Surgeons: The Mayo Clinic Experience in 17,634 Sedations (2004 to 2019),” Journal of Oral and Maxillofacial Surgery, by Kevin Arce, DMD, MD, FACS; Kyle S. Ettinger, DDS, MD; William J. Fillmore, DMD, MD; Benjamin T. Heggestad, DDS, MD; John M. Nathan, DDS, MD; James M. Van Ess, DDS, MD; Christopher F. Viozzi, DDS, MD; and Steven J. Wiemer, DDS, MD, all of Rochester, Minn.

Share article on social media or email:

Shark Discoveries and Kevin Harrington Launch BRTV Campaign with Reliable Blends


After identifying areas of need in the health and wellness industry, Reliable Blends made it their mission to find new, novel and all-natural solutions to deliver reliable products that solve real problems. After several years of research and development, Reliable Blends’ team of physicians and health care specialists created a physician-formulated health and wellness product line that delivers high quality results and improves quality of life.

Manufactured in small batches, using pure, clinically-proven ingredients, Reliable Blends delivers products of the highest standards. With so many products in the market that are not the quality that is claimed, Reliable Blends has made it their sole focus and mission to provide products and formulations that truly benefit their customers. They offer all-natural, lab tested products ranging from pain relief creams and headache balms to overall health and wellness products.

“Effectively leading an organization whose mission it is to reach those who need our products the most, mandates an absolute understanding of the responsibility we bear and the ethics required,” said Steve Alasi, Chairman and CEO of Reliable Blends. “Our priority is to bring products to market that offer solutions to the problems people face on a daily basis; products that touch and change lives in a beneficial and empowering way, and in fulfilling this commitment, Reliable Blends will flourish.”

“We are excited to be working with Shark Discoveries to accomplish these goals.”

“Reliable Blends provides high quality results,” says Doug Scott, Executive Producer at Shark Discoveries. “They are a brand you can trust.”

“Reliable Blends is a company you can trust, using proven, all natural and lab tested ingredients with the addition of pure hemp isolate in all of their products,” says Kevin Harrington, inventor of the infomercial and Original Shark on Shark Tank. “I’m proud to support and use Reliable Blends Products and highly recommend them to everyone.”

As part of its BRTV campaign with Shark Discoveries, Reliable Blends will be appearing in 60 second spots set to air nationwide and feature the original Shark himself, Kevin Harrington. Shark Discoveries is an award-winning team of producers, writers, videographers, and editors as well as industry veterans dedicated to finding the latest, most innovative products and ideas, and putting them on the BRTV map.

About Shark Discoveries

Headquartered in South Florida, Shark Discoveries is a full-service production, branding, and marketing company that specializes in brand response television, including Celebrity Influencer Videos, and brand building. Based out of a 25,000+sq ft, state-of-the-art studio, the company’s creative team handles every aspect of production from script to screen to airing. About Kevin Harrington As the inventor of the infomercial, founder of As Seen on TV, and one of the original Sharks on Shark Tank, Kevin Harrington has worked with some of the world’s biggest celebrities and launched some of the best-selling DRTV campaigns in history. Since producing his first 30-minute infomercial in 1984, Harrington has been involved in more than 500 product launches that have resulted in more than $5 billion in sales. Now, in his latest venture with Shark Discoveries, Harrington is on the hunt for the best new products and ideas, bringing them to homes everywhere through personalized BRTV campaigns featuring the Shark.

For more information on Reliable Blends, please visit http://www.ReliableBlends.com.

Share article on social media or email: